Zydus Lifesciences Shares Gain 1% on Receiving USFDA Approval
Shares of Zydus Lifesciences were trading in the green and 1% higher on 18 October after the company received approval from the US Food and...
Tag : USFDA approval
Zydus Lifesciences Secures Final USFDA Approval for Schizophrenia Drug, Shares Close Flat
Shares of Zydus Lifesciences Ltd. ended flat after hitting a day’s high of Rs 1,070.50 on 11th October, despite the firm announcing yesterday that it...
Alembic Pharma Shares Reach 52-Week High After USFDA Approval
Shares of Alembic Pharmaceuticals Ltd. rose nearly 4%, reaching a day’s high of Rs 1,303.90 on 9th October, after the company announced that the United...
Zydus Lifesciences Shares Gain 1% on Securing USFDA Final Approval
Shares of Zydus Lifesciences Ltd saw a 1% increase during the early trading hours on 30 September after the company announced receiving final approval from...
Aurobindo Pharma Arm Receives USFDA Nod for Andhra Pradesh Facility; Shares Down 1%
Shares of Aurobindo Pharma Ltd. dropped 1% from a day’s high of Rs 1,559.90 on 18th September after the company announced that its step-down subsidiary,...
Aurobindo Pharma Arm Gets USFDA Approval
Aurobindo Pharma Ltd on Wednesday 11 September announced that its new injectable facility in Andhra Pradesh has secured its first product approval from the US...
Strides Pharma Rises Nearly 4% on USFDA Approval for Respiratory Drug from Singapore Arm
Shares of Strides Pharma Science Ltd. surged nearly by 4% to a day’s high of Rs 1,395 on 6th September, after the company’s subsidiary received...
Granules India Shares Rise 2% After USFDA Approval for Antidepressant Drug
Shares of Granules India Ltd. rose by nearly 2% to touch a day’s high of Rs 666.30 on 9th August after the USFDA approved its...
Sun Pharma Receives USFDA Approval for Alopecia Treatment Drug; Shares Jump 3%
Shares of Sun Pharmaceutical Industries Ltd. surged by almost 3% to touch a day’s high of Rs 1,712.40 on 26 July after announcing USFDA approval...
Alembic Pharma Gains 10% After USFDA Approval for Antipsychotic Drug
Shares of Alembic Pharmaceuticals Ltd. rose by almost 10% to touch a 52-week high of Rs 1,192.75 on 24 July after the company announced securing...